HER-2 status of the primary breast cancer in patients with late disease relapse

被引:0
|
作者
Tomasevic, Zorica [1 ]
Jovanovic, Danica [1 ]
Radosevic-Jelic, Ljiljana [1 ]
Tomasevic, Zoran [1 ]
Vasovic, Suzana [1 ]
Stamatovic, Ljiljana [1 ]
Jelic, Svetislav [1 ]
Spasic, Jelena [1 ]
机构
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [41] PEA3 expression in breast cancer patients of known HER-2/NEU status
    Myers, E
    Hill, ADK
    Buggy, Y
    McDermott, EW
    O'Higgins, NJ
    Young, LS
    BRITISH JOURNAL OF SURGERY, 2003, 90 (05) : 624 - 625
  • [42] HER-2 testing in breast cancer
    Tubbs, RR
    Hicks, DG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (15): : 1817 - 1818
  • [43] Her-2/neu and breast cancer
    Kaptain, S
    Tan, LK
    Chen, BY
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2001, 10 (03) : 139 - 152
  • [44] DISCORDANCE BETWEEN HORMONE RECEPTORS AND HER2 STATUS IN BREAST CANCER PATIENTS RELAPSE
    Roque, Katia
    Otoya, Iris
    Valdivieso, Natalia
    Morante, Zaida
    Fuentes, Hugo
    Neciosup, Silvia
    Gomez, Henry
    Cotito, Jorge
    Ziegler, Gonzalo
    Pena, Estefania
    Vidaurre, Tatiana
    de Mello, Ramon Andrade
    Castaneda, Carlos
    CANCER RESEARCH, 2024, 84 (09)
  • [45] Her-2/neu and topoisomerase IIaexpression in primary and metastatic breast cancer
    Cardoso F.
    Breast Cancer Research, 3 (1)
  • [46] Serum HER-2/neu in the management of breast cancer patients
    Lüftner, D
    Lüke, C
    Possinger, K
    CLINICAL BIOCHEMISTRY, 2003, 36 (04) : 233 - 240
  • [47] Preliminary study of serum HER-2/neu detection in primary breast cancer patients.
    Thriveni, K.
    Deshmane, V
    Bapsy, P. P.
    Krishnamoorthy, L.
    Kidwai, Ramaswamy G.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S41
  • [48] HER-2 therapy. HER-2/neu diagnostics in breast cancer
    Walter P Carney
    Kim Leitzel
    Suhail Ali
    Rainer Neumann
    Allan Lipton
    Breast Cancer Research, 9
  • [49] Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer
    Salvadori, B
    Pinzani, P
    Distante, V
    Casella, D
    Bianchi, S
    Paglierani, M
    Vezzosi, V
    Neumann, R
    Cataliotti, L
    Pazzagli, M
    Orlando, C
    CLINICAL CHEMISTRY, 2005, 51 (01) : 254 - 256
  • [50] HER2-low breast cancer: Evolution from primary breast cancer to relapse
    Miglietta, F.
    Griguolo, G.
    Bottosso, M.
    Giarratano, T.
    Lo Mele, M.
    Fassan, M.
    Cacciatore, M.
    Genovesi, E.
    De Bartolo, D.
    Vernaci, G.
    Conte, P. F.
    Guarneri, V.
    Dieci, M. V.
    ANNALS OF ONCOLOGY, 2021, 32 : S23 - S23